ClinicalTrials.gov
public full text
Public Domain
Safety Study on AdCD40L Gene Therapy for Bladder Cancer
The study objective is to evaluate the feasibility of three instillations of immunostimulating gene therapy (AdCD40L) in patients with urinary bladder cancer. Tolerance, toxicity and immunological parameters will be evaluated during and post treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.#670818
- Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer#844589
- Antitumor T Cell Responses in Patients With Bladder Cancer#1185232
- Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer#831155
- Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer#1294779
Record · ID 1213820
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive